LUDELLA MCCULLOUGH-LEE: Open Payments
NPI 1093409369 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 12 payments from 6 companies in 2025. Trend: 2023 $46 · 2024 $42 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $170 |
| Alkermes, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, INGREZZA.
Industry payments across AZ — which companies pay providers there.
